Onco-Innovations Appoints Dr. John Mackey to Advisory Board

Onco-Innovations Limited has announced the appointment of Dr. John Mackey to its Scientific and Clinical Advisory Board. Dr. Mackey, Professor Emeritus at the University of Alberta, brings vast oncology and clinical trial expertise. His role will aid Onco's translation of research into clinical practice, especially in advancing the PNKP inhibitor program.

Dr. Mackey's experience includes serving as Director of Clinical Trial Unit at Cross Cancer Institute and Executive Director at TRIO. He co-founded Pacylex Pharmaceuticals, involved in Phase II trials, and leads illumiSonics, focusing on molecular histology technology. With 12 patents and over 300 publications, Dr. Mackey's insights will guide Onco's clinical strategies, aiding their mission in cancer research.